Control of central and peripheral tolerance to melanocyte differentiation antigens by GILT

Journal of Investigative Dermatology

Volumn 132, Issue 1, 2012, Pages 15-17

  Becker, Jürgen C ^a   Schrama, David ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CELL ANTIGEN; GAMMA INTERFERON; INTERFERON GAMMA INDUCIBLE LYSOSOMAL THIOL REDUCTASE; INTERLEUKIN 2; MELANOCYTE DIFFERENTIATION ANTIGEN; OXIDOREDUCTASE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MELANOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; THYMUS;

EID: 84856106022     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.361     Document Type: Note

References (11)

1. Andersen MH, Schrama D, Thor Straten P et al. (2006) Cytotoxic T cells. J Invest Dermatol 126:32-41 (Pubitemid 43336091)
2. Becker JC, Guldberg P, Zeuthen J et al. (1999) Accumulation of identical T cells in melanoma and vitiligo-like leukoderma. J Invest Dermatol 113:1033-8 (Pubitemid 30013349)
3. Delfino DV, Pozzesi N, Pierangeli S et al. (2011) Manipulating thymic apoptosis for future therapy of autoimmune disease. Curr Pharm Des; epub ahead of print 25 August 2011
4. Derbinski J, Kyewski B (2010) How thymic antigen presenting cells sample the body's selfantigens. Curr Opin Immunol 22:592-600
5. Goldstein OG, Hajiaghamohseni LM, Amria S et al. (2008) Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma. Cancer Immunol Immunother 57:1461-70
6. Metzger TC, Anderson MS (2011) Control of central and peripheral tolerance by Aire. Immunol Rev 241:89-103
7. Moon JJ, Dash P, Oguin TH 3rd et al. (2011) Quantitative impact of thymic selection on Foxp3+ and Foxp3? subsets of self-peptide/MHC class II-specific CD4+ T cells. Proc Natl Acad Sci USA 108:14602-7
8. Moran AE, Holzapfel KL, Xing Y et al. (2011) T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J Exp Med 208:1279-89
9. Muranski P, Boni A, Antony PA et al. (2008) Tumorspecific Th17-polarized cells eradicate large established melanoma. Blood 112:362-73
10. Rausch MP, Irvine KR, Antony PA et al. (2010) GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1. J Immunol 185:2828-35
11. Rausch MP, Hastings KT (2012) GILT modulates CD4+ T-cell tolerance to the melanocyte differentiation antigen tyrosinase-related protein 1. J Invest Dermatol 132:154-62